CAPITOL HILL CONSULTING GROUP

Lobbying for OCULAR THREPEUTIX · Biopharmaceutical company focused on therapies for the eye.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $20,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to Medicare reimbursement for therapies of the eye.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.